UOTTAIMCU
AGIO icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Agios Pharmaceuticals AGIO Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-40,000
Closed -$1.68M – 26
2016
Q2 		$1.68M Buy
+40,000
New +$1.98M 4.87% 9

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s AGIO Position: Q3 2016 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Agios Pharmaceuticals (AGIO) in Q3 2016, closing a stake of 40,000 shares — an estimated $1.68M sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in AGIO in Q2 2016 and held it in 1 quarter. The position peaked at $1.68M in Q2 2016. 163 funds tracked by Wall St. Rank hold AGIO as of Q3 2016.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Agios Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 40,000 Agios Pharmaceuticals shares in Q3 2016, an estimated $1.68M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Agios Pharmaceuticals in Q2 2016 and held it in 1 quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Agios Pharmaceuticals position peaked at $1.68M in Q2 2016.
  • 163 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2016.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q3 2016, filed 3 Nov 2016.